Based on 1 Wall Street analysts offering 12 month price targets for Shanghai Fosun Pharmaceutical (Group) Co in the last 3 months. The average price target is $1.82 with a high forecast of $1.82 and a low forecast of $1.82. The average price target represents a 12.35% change from the last price of $1.62.

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

Highest Price Target$1.82

Average Price Target$1.82

Lowest Price Target$1.82

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SFOSF Analyst Recommendation Trends

Currently, no data available

Please return soon. This page is being updated.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SFOSF Financial Forecast

SFOSF Earnings Forecast

Next quarter’s earnings estimate for SFOSF is $0.04 with a range of $0.03 to $0.05. The previous quarter’s EPS was $0.04. SFOSF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.51% of the time in the same period. In the last calendar year SFOSF has Preformed in-line its overall industry.

SFOSF Sales Forecast

Next quarter’s sales forecast for SFOSF is $1.48B with a range of $1.48B to $1.48B. The previous quarter’s sales results were ―. SFOSF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 53.85% of the time in the same period. In the last calendar year SFOSF has Outperformed its overall industry.

SFOSF Stock Forecast FAQ

What is SFOSF’s average 12-month price target, according to analysts?

Based on analyst ratings, Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s 12-month average price target is $1.82.

What is SFOSF’s upside potential, based on the analysts’ average price target?

Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has 12.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SFOSF a Buy, Sell or Hold?

Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price target?

The average price target for Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H is $1.82. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.82 ,the lowest forecast is $1.82. The average price target represents 12.35% Increase from the current price of $1.62.

What do analysts say about Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?

Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of SFOSF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing